Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax

NCT03569514 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Anthrax

Interventions

DRUG: AIGIV

Sponsor

Emergent BioSolutions

Collaborators

[object Object]
[object Object]